시장보고서
상품코드
1460217

바이오프로세스 분석기 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

Bioprocess Analyzers Market (Product: Instruments and Consumables & Accessories: and Application: Antibiotics, Recombinant Proteins, Biosimilars, and Monoclonal Antibodies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

발행일: | 리서치사: Transparency Market Research | 페이지 정보: 영문 186 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

바이오프로세스 분석기 시장 - 조사 범위

TMR의 조사 보고서 "바이오프로세스 분석기 세계 시장"은 2023년부터 2031년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 2023년을 기준 연도로, 2031년을 예측 연도로 삼아 과거뿐만 아니라 현재의 성장 동향과 기회도 조사했습니다, 2017년부터 2031년까지 세계 바이오프로세스 분석기 시장의 수익과 예측을 제공합니다. 또한 2023년부터 2031년까지 세계 바이오프로세스 분석기 시장의 복합 연간 성장률(CAGR%)도 제공합니다.

이 보고서는 광범위한 1차 조사, KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체와의 인터뷰, 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 문서 등을 참고한 2차 조사를 통해 바이오프로세스 분석기 시장을 파악했습니다. 분석기 시장을 파악하였습니다.

시장 현황
2022년 시장 가치 19억 달러
2031년 시장 가치 40억 달러
CAGR 8.9%

이 보고서는 세계 바이오프로세스 분석기 시장의 경쟁 환경에 대해 자세히 조사했습니다. 세계 바이오프로세스 분석기 시장에서 사업을 운영하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 시장 개발, SWOT는 이 보고서에 소개된 세계 바이오프로세스 분석기 시장 기업의 속성입니다.

목차

제1장 서문

제2장 조사의 전제조건과 조사 방법

제3장 주요 요약 : 바이오프로세스 분석기 시장

제4장 시장 개요

  • 서론
  • 시장 개요
  • 시장 역학
  • 바이오프로세스 분석기 시장 분석과 예측, 2017-2031년

제5장 주요 인사이트

  • 파이프라인 분석
  • 주요 기술, 브랜드 분석
  • 주요 M&A
  • COVID-19 팬데믹의 산업에 대한 영향

제6장 바이오프로세스 분석기 시장 분석과 예측 : 제품별

  • 서론과 정의
  • 주요 조사 결과/발전
  • 시장 매출 예측 : 제품별, 2017-2031년
    • 기기
    • 소모품 및 액세서리
  • 시장의 매력 분석 : 제품별

제7장 바이오프로세스 분석기 시장 분석과 예측 : 용도별

  • 서론과 정의
  • 주요 조사 결과/발전
  • 시장 매출 예측 : 용도별, 2017년-2031년
    • 항생제
    • 재조합 단백질
    • 바이오시밀러
    • 단클론항체
  • 시장의 매력 분석 : 용도별

제8장 바이오프로세스 분석기 시장 분석과 예측 : 최종사용자별

  • 서론과 정의
  • 주요 조사 결과/발전
  • 시장 매출 예측 : 최종사용자별, 2017년-2031년
    • 바이오의약품 기업
    • CMO
    • CRO
    • 기타
  • 시장의 매력 분석 : 용도별

제9장 바이오프로세스 분석기 시장 분석과 예측 : 지역별

  • 주요 조사 결과
  • 시장 매출 예측 : 지역별, 2017년-2031년
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 시장의 매력 분석 : 지역별

제10장 북미의 바이오프로세스 분석기 시장 분석과 예측

제11장 유럽의 바이오프로세스 분석기 시장 분석과 예측

제12장 아시아태평양 땅의 바이오프로세스 분석기 시장 분석과 예측

제13장 라틴아메리카의 바이오프로세스 분석기 시장 분석과 예측

제14장 중동 및 아프리카의 바이오프로세스 분석기 시장 분석과 예측

제15장 경쟁 구도

  • 시장 경쟁 매트릭스(Tier별·규모별)
  • 시장 점유율 분석 : 기업별(2022년)
  • 기업 개요
    • Nova Biomedical
    • Sartorius Group
    • F. Hoffmann-La Roche Ltd.
    • SYSBIOTECH GmbH
    • Kaiser Optical Systems, Inc.
    • YSI, Inc.(Xylem, Inc.)
    • Randox Laboratories Ltd.
LSH 24.05.14

Bioprocess Analyzers Market - Scope of Report

TMR's report on the global bioprocess analyzers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global bioprocess analyzers market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global bioprocess analyzers market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the bioprocess analyzers market.

Market Snapshot
Market Value in 2022US$ 1.9 Bn
Market Value in 2031US$ 4 Bn
CAGR8.9%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global bioprocess analyzers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global bioprocess analyzers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global bioprocess analyzers market.

The report delves into the competitive landscape of the global bioprocess analyzers market. Key players operating in the global bioprocess analyzers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global bioprocess analyzers market profiled in this report.

Key Questions Answered in Global bioprocess analyzers Market Report:

  • What is the sales/revenue generated by bioprocess analyzers across all regions during the forecast period?
  • What are the opportunities in the global bioprocess analyzers market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Bioprocess Analyzers Market - Research Objectives and Research Approach

The comprehensive report on the global bioprocess analyzers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global bioprocess analyzers market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global bioprocess analyzers market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Bioprocess Analyzers Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Technology, Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Bioprocess Analyzers Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Technology, /Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Bioprocess Analyzers Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Instruments
    • 6.3.2. Consumables & Accessories
  • 6.4. Market Attractiveness Analysis, by Product,

7. Bioprocess Analyzers Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Antibiotics
    • 7.3.2. Recombinant Proteins
    • 7.3.3. Biosimilars
    • 7.3.4. Monoclonal Antibodies
  • 7.4. Market Attractiveness Analysis, by Application

8. Bioprocess Analyzers Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Biopharmaceutical Companies
    • 8.3.2. Contract Manufacturing Organizations
    • 8.3.3. Contract Research Organizations
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by Application

9. Bioprocess Analyzers Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Bioprocess Analyzers Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Product, 2017-2031
    • 10.3.1. Instruments
    • 10.3.2. Consumables & Accessories
  • 10.4. Market Value Forecast, by Application, 2017-2031
    • 10.4.1. Antibiotics
    • 10.4.2. Recombinant Proteins
    • 10.4.3. Biosimilars
    • 10.4.4. Monoclonal Antibodies
  • 10.5. Market Value Forecast, by End-user, 2017-2031
    • 10.5.1. Biopharmaceutical Companies
    • 10.5.2. Contract Manufacturing Organizations
    • 10.5.3. Contract Research Organizations
    • 10.5.4. Others
  • 10.6. Market Value Forecast, by Country, 2017-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Product,
    • 10.7.2. By Application
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Bioprocess Analyzers Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Product, 2017-2031
    • 11.3.1. Instruments
    • 11.3.2. Consumables & Accessories
  • 11.4. Market Value Forecast, by Application, 2017-2031
    • 11.4.1. Antibiotics
    • 11.4.2. Recombinant Proteins
    • 11.4.3. Biosimilars
    • 11.4.4. Monoclonal Antibodies
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Biopharmaceutical Companies
    • 11.5.2. Contract Manufacturing Organizations
    • 11.5.3. Contract Research Organizations
    • 11.5.4. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product,
    • 11.7.2. By Application
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Bioprocess Analyzers Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Product, 2017-2031
    • 12.3.1. Instruments
    • 12.3.2. Consumables & Accessories
  • 12.4. Market Value Forecast, by Application, 2017-2031
    • 12.4.1. Antibiotics
    • 12.4.2. Recombinant Proteins
    • 12.4.3. Biosimilars
    • 12.4.4. Monoclonal Antibodies
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Biopharmaceutical Companies
    • 12.5.2. Contract Manufacturing Organizations
    • 12.5.3. Contract Research Organizations
    • 12.5.4. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product,
    • 12.7.2. By Application
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Bioprocess Analyzers Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Product, 2017-2031
    • 13.3.1. Instruments
    • 13.3.2. Consumables & Accessories
  • 13.4. Market Value Forecast, by Application, 2017-2031
    • 13.4.1. Antibiotics
    • 13.4.2. Recombinant Proteins
    • 13.4.3. Biosimilars
    • 13.4.4. Monoclonal Antibodies
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Biopharmaceutical Companies
    • 13.5.2. Contract Manufacturing Organizations
    • 13.5.3. Contract Research Organizations
    • 13.5.4. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product,
    • 13.7.2. By Application
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Bioprocess Analyzers Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Product, 2017-2031
    • 14.3.1. Instruments
    • 14.3.2. Consumables & Accessories
  • 14.4. Market Value Forecast, by Application, 2017-2031
    • 14.4.1. Antibiotics
    • 14.4.2. Recombinant Proteins
    • 14.4.3. Biosimilars
    • 14.4.4. Monoclonal Antibodies
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Biopharmaceutical Companies
    • 14.5.2. Contract Manufacturing Organizations
    • 14.5.3. Contract Research Organizations
    • 14.5.4. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product
    • 14.7.2. By Application
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Nova Biomedical
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Technology, Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Sartorius Group
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Technology, Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. F. Hoffmann-La Roche Ltd.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Technology, Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. SYSBIOTECH GmbH
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Technology, Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Kaiser Optical Systems, Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Technology, Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. YSI, Inc. (Xylem, Inc.)
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Technology, Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Randox Laboratories Ltd.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Technology, Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제